| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dialysis |
For the Mexican Nephrology Collaborative Study Group, * Unidad de Investigacioñ Médica en Enfermedades Nefrolìicas, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Astellas Pharma US, Deerfield, Illinois; Northwestern University, Evanston, Illinois; Instituto Mexicano del Seguro Social, Hermosillo, Mexico; || Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico; and ¶ Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
Correspondence: Dr. Salim Mujais, 2742 The Mews, Northbrook, IL 60062. Phone: 847-317-5468; Fax: 847-317-8861; E-mail: salim.mujais{at}gmail.com
Background and objectives: Natriuretic peptides have been suggested to be of value in risk stratification in dialysis patients. Data in patients on peritoneal dialysis remain limited.
Design, setting, participants, & measurements: Patients of the ADEMEX trial (ADEquacy of peritoneal dialysis in MEXico) were randomized to a control group [standard 4 x 2L continuous ambulatory peritoneal dialysis (CAPD); n = 484] and an intervention group (CAPD with a target creatinine clearance 
60L/wk/1.73 m2; n = 481). Natriuretic peptides were measured at baseline and correlated with other parameters as well as evaluated for effects on patient outcomes.
Results: Control group and intervention group were comparable at baseline with respect to all measured parameters. Baseline values of natriuretic peptides were elevated and correlated significantly with levels of residual renal function but not with body size or diabetes. Baseline values of N-terminal fragment of B-type natriuretic peptide (NT-proBNP) but not proANP(1–30), proANP(31–67), or proANP(1–98) were independently highly predictive of overall survival and cardiovascular mortality. Volume removal was also significantly correlated with patient survival.
Conclusions. NT-proBNP have a significant predictive value for survival of CAPD patients and may be of value in guiding risk stratification and potentially targeted therapeutic interventions.
This article has been cited by other articles:
|
|
 |
|
  E. Vonesh ON SMALL SOLUTE CLEARANCE AND PATIENT OUTCOMES: EVIDENTIAL PRACTICE OR OBSERVATIONAL TREPIDATION? Perit. Dial. Int., November 1, 2009; 29(6): 623 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Paniagua, M.-d.-J. Ventura, M. Avila-Diaz, H. Hinojosa-Heredia, A. Mendez-Duran, A. Cueto-Manzano, A. Cisneros, A. Ramos, C. Madonia-Juseino, F. Belio-Caro, et al. NT-proBNP, Fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients Nephrol. Dial. Transplant., August 12, 2009; (2009) gfp395v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Paniagua, M.-d.-J. Ventura, M. Avila-Diaz, A. Cisneros, M. Vicente-Martinez, M.-d.-C. Furlong, Z. Garcia-Gonzalez, D. Villanueva, O. Orihuela, M.-d.-C. Prado-Uribe, et al. ICODEXTRIN IMPROVES METABOLIC AND FLUID MANAGEMENT IN HIGH AND HIGH-AVERAGE TRANSPORT DIABETIC PATIENTS Perit. Dial. Int., July 1, 2009; 29(4): 422 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Piraino, E. Minev, J. Bernardini, and F. H. Bender DOES EXPERIENCE WITH PD MATTER? Perit. Dial. Int., May 1, 2009; 29(3): 256 - 261. [Full Text] [PDF]
|
|
|
|
|
|
S. Davies, O. Carlsson, O. Simonsen, A.-C. Johansson, D. Venturoli, I. Ledebo, A. Wieslander, C. Chan, and B. Rippe The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1609 - 1617. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
